Olink

The study lends support to the case for dried blood spots as a proteomics sample source for applications like biobanking and longitudinal patient monitoring.

Some six months after establishing itself as an independent entity, the company plans to roughly double its protein biomarker libraries by the end of the year.

The company said its new Massachusetts office will focus on driving US sales of its Proseek Multiplex platform for targeted human protein biomarker discovery.

The new company, Olink Proteomics, will focus on the Proseek Platform for protein detection, while the remaining firm will look to commercialize other parts of its IP portfolio.

Olink Proteomics will focus on developing protein biomarker discovery products while Olink Bioscience will work on other technologies arising from its IP portfolio.

Based on Olink's proximity ligation technology, Duolink allows for detection of low-abundance proteins with higher specificity than conventional immunoassays.

Eliminating enzymes makes for a less expensive and more accessible assay that could prove useful for purposes like infectious disease testing in developing countries.

New Products: Olink Biosciences

Premium

Olink Bioscience has launched its new Proseek Multiplex Inflammation protein biomarker panel.

NEW YORK (GenomeWeb) – Researchers from Olink Biosciences have completed an optimization study of the company's Proseek protein assay, demonstrating the feasibility of performing the assay in a 96-plex format while achieving significant improvements in precision.

Olink Bioscience this week launched Proseek Multiplex CVD I 96x96, a new protein biomarker panel for cardiovascular disease.

Pages

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.